| Ricardo E Chambi Md | |
|
8225 Long Beach Blvd Suite C South Gate CA 90280-2010 | |
| (323) 585-1056 | |
| Not Available |
| Full Name | Ricardo E Chambi Md |
|---|---|
| Speciality | General Practice |
| Location | 8225 Long Beach Blvd, South Gate, California |
| Authorized Official Name and Position | Ricardo E Chambi (PRESIDENT) |
| Authorized Official Contact | 3235851056 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ricardo E Chambi Md Po Box 3429 Huntington Park CA 90255-2329 Ph: (323) 585-1056 | Ricardo E Chambi Md 8225 Long Beach Blvd Suite C South Gate CA 90280-2010 Ph: (323) 585-1056 |
| NPI Number | 1295887024 |
|---|---|
| Provider Enumeration Date | 01/18/2007 |
| Last Update Date | 09/24/2016 |
| Medicare PECOS PAC ID | 1254368699 |
|---|---|
| Medicare Enrollment ID | O20050718000875 |
News Archive
In a significant advance for cosmetic and reconstructive medicine, scientists at Rice University have unveiled a new method for making synthetic collagen. The new material, which forms from a liquid in as little as an hour, has many of the properties of natural collagen and may prove useful as a scaffold for regenerating new tissues and organs from stem cells.
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of the proteins in the body. The TUM spin-off XL-Protein GmbH has now started to further develop this new technology with blockbuster potential.
Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the launch of the Bifurcation Institute. The Bifurcation Institute is a comprehensive education resource established to advance the standard of care for bifurcated coronary artery disease, a common, and often untreated, clinical need.
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced completion of a research report concerning its fluorescent stem cells, http://www.vitrobiopharma.com/wp-content/uploads/2009/10/fluorescent-msc-10-3.pdf. This report revealed transfer of fluorescent to differentiated cells including chondrocytes, cells responsible for making cartilage.
A study by the University of Southampton examining non-pharmaceutical interventions (NPIs) in response to the new coronavirus (COVID-19) in China shows that a range of early, coordinated and targeted measures are needed to help significantly reduce its spread.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295887024 | NPI | - | NPPES |
| GR0101040 | Medicaid | CA | |
| 00A453841 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | A45384 (California) | Primary |
| Provider Name | Ricardo E Chambi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1518905181 PECOS PAC ID: 1951338300 Enrollment ID: I20050718000908 |
News Archive
In a significant advance for cosmetic and reconstructive medicine, scientists at Rice University have unveiled a new method for making synthetic collagen. The new material, which forms from a liquid in as little as an hour, has many of the properties of natural collagen and may prove useful as a scaffold for regenerating new tissues and organs from stem cells.
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of the proteins in the body. The TUM spin-off XL-Protein GmbH has now started to further develop this new technology with blockbuster potential.
Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the launch of the Bifurcation Institute. The Bifurcation Institute is a comprehensive education resource established to advance the standard of care for bifurcated coronary artery disease, a common, and often untreated, clinical need.
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced completion of a research report concerning its fluorescent stem cells, http://www.vitrobiopharma.com/wp-content/uploads/2009/10/fluorescent-msc-10-3.pdf. This report revealed transfer of fluorescent to differentiated cells including chondrocytes, cells responsible for making cartilage.
A study by the University of Southampton examining non-pharmaceutical interventions (NPIs) in response to the new coronavirus (COVID-19) in China shows that a range of early, coordinated and targeted measures are needed to help significantly reduce its spread.
› Verified 8 days ago
| Provider Name | Elvira P Flores |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326325069 PECOS PAC ID: 1850477977 Enrollment ID: I20161019001442 |
News Archive
In a significant advance for cosmetic and reconstructive medicine, scientists at Rice University have unveiled a new method for making synthetic collagen. The new material, which forms from a liquid in as little as an hour, has many of the properties of natural collagen and may prove useful as a scaffold for regenerating new tissues and organs from stem cells.
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of the proteins in the body. The TUM spin-off XL-Protein GmbH has now started to further develop this new technology with blockbuster potential.
Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the launch of the Bifurcation Institute. The Bifurcation Institute is a comprehensive education resource established to advance the standard of care for bifurcated coronary artery disease, a common, and often untreated, clinical need.
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced completion of a research report concerning its fluorescent stem cells, http://www.vitrobiopharma.com/wp-content/uploads/2009/10/fluorescent-msc-10-3.pdf. This report revealed transfer of fluorescent to differentiated cells including chondrocytes, cells responsible for making cartilage.
A study by the University of Southampton examining non-pharmaceutical interventions (NPIs) in response to the new coronavirus (COVID-19) in China shows that a range of early, coordinated and targeted measures are needed to help significantly reduce its spread.
› Verified 8 days ago
News Archive
In a significant advance for cosmetic and reconstructive medicine, scientists at Rice University have unveiled a new method for making synthetic collagen. The new material, which forms from a liquid in as little as an hour, has many of the properties of natural collagen and may prove useful as a scaffold for regenerating new tissues and organs from stem cells.
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of the proteins in the body. The TUM spin-off XL-Protein GmbH has now started to further develop this new technology with blockbuster potential.
Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the launch of the Bifurcation Institute. The Bifurcation Institute is a comprehensive education resource established to advance the standard of care for bifurcated coronary artery disease, a common, and often untreated, clinical need.
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced completion of a research report concerning its fluorescent stem cells, http://www.vitrobiopharma.com/wp-content/uploads/2009/10/fluorescent-msc-10-3.pdf. This report revealed transfer of fluorescent to differentiated cells including chondrocytes, cells responsible for making cartilage.
A study by the University of Southampton examining non-pharmaceutical interventions (NPIs) in response to the new coronavirus (COVID-19) in China shows that a range of early, coordinated and targeted measures are needed to help significantly reduce its spread.
› Verified 8 days ago
Saint Joseph Family Medical Clinic, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2643 Santa Ana St, South Gate, CA 90280 Phone: 323-277-9010 Fax: 323-277-9012 | |
Mission San Juan Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9914 San Juan Ave, South Gate, CA 90280 Phone: 323-564-1100 | |
Clinica Maria Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8100 California Ave, Suite K, South Gate, CA 90280 Phone: 323-357-1000 Fax: 323-357-1001 | |
Torreblanca Medical Clinic Incorporated Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10001 California Ave, South Gate, CA 90280 Phone: 323-564-4408 Fax: 323-564-5447 | |
La Libertad Medical Clinic Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8427 Long Beach Blvd, South Gate, CA 90280 Phone: 323-585-2486 Fax: 562-943-7518 | |
Chander Medical Associates Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9844 Atlantic Ave, Suite #a, South Gate, CA 90280 Phone: 310-631-3502 Fax: 310-631-5143 | |
Maria Auxiliadora Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9401 Long Beach Blvd, South Gate, CA 90280 Phone: 323-582-8612 Fax: 323-567-9784 |